To include your compound in the COVID-19 Resource Center, submit it here.

Diffusion to start Phase III GBM trial of TSC

By year end, Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) will begin a Phase III trial to compare

Read the full 157 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE